Cargando…
Downregulation of NKG2DLs by TGF-β in human lung cancer cells
BACKGROUND: Transforming growth factor beta (TGF-β) is a typical immuno-inhibitory cytokine and highly secreted by lung cancer cells. It was supposed that its immunosuppressive effects to NK cell might be related with the altered expression of activating and inhibitory molecules in lung cancer cells...
Autores principales: | Lee, Young Shin, Choi, Hojung, Cho, Hae-Ryung, Son, Woo-Chang, Park, You-Soo, Kang, Chi-Dug, Bae, Jaeho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273967/ https://www.ncbi.nlm.nih.gov/pubmed/34253166 http://dx.doi.org/10.1186/s12865-021-00434-8 |
Ejemplares similares
-
Differential Effects of Histone Deacetylases on the Expression of NKG2D Ligands and NK Cell-Mediated Anticancer Immunity in Lung Cancer Cells
por: Cho, Haeryung, et al.
Publicado: (2021) -
The TGF‐β‐induced up‐regulation of NKG2DLs requires AKT/GSK‐3β‐mediated stabilization of SP1
por: Chen, Xiao‐Hui, et al.
Publicado: (2017) -
Upregulation of Myc promotes the evasion of NK cell-mediated immunity through suppression of NKG2D ligands in K562 cells
por: Lee, Young-Shin, et al.
Publicado: (2019) -
An inhibitor of programmed death ligand 1 enhances natural killer cell-mediated immunity against malignant melanoma cells
por: Lee, Young Shin, et al.
Publicado: (2021) -
CAR-T cells dual-target CD123 and NKG2DLs to eradicate AML cells and selectively target immunosuppressive cells
por: Jin, Xin, et al.
Publicado: (2023)